Dejar Mensaje
YLMACHINE Heavy Industry entrenará a sus operadores, ofrecer visitas de seguimiento para revisar el uso del equipo, y el asesoramiento sobre la utilización óptima de las piezas de desgaste.
Caso de línea de producción de productos
bonalive biomaterials prnewswire
Bonalive® Biomaterials Ltd. granted FDA Breakthrough Device ...
TURKU, Finland, Feb. 16, 2022 /PRNewswire/ -- The Center for Devices and Radiological Health at the Food Drug Administration has determined that Bonalive ® Orthopedics
Charlar en LíneaBonAlive Biomaterials Ltd Receives CE-mark for Osteostimulative ...
2013.11.22 BonAlive Biomaterials Ltd, a manufacturer of implantable medical devices, today announced the launch of a patented, ready-to-use and mouldable version
Charlar en LíneaOlympus Biotech International Ltd and BonAlive Biomaterials Ltd ...
2013.1.21 BonAlive Biomaterials Ltd, a manufacturer of implantable medical devices and an emerging leader in indications involving the treatment of chronically
Charlar en LíneaPR Newswire - Olympus Biotech International Ltd y BonAlive
2013.1.21 /PRNewswire/ -- BonAlive Biomaterials Ltd, un fabricante de dispositivos médicos implantables y líder emergente en indicaciones en las que están implicadas el...
Charlar en LíneaOlympus Biotech International Ltd and BonAlive Biomaterials Ltd ...
2013.1.21 /PRNewswire/ -- BonAlive Biomaterials Ltd, a manufacturer of implantable medical devices and an emerging leader in indications involving the
Charlar en LíneaBonalive® Biomaterials Ltd. granted FDA Breakthrough Device ...
2022.2.16 Bonalive® Biomaterials Ltd. granted FDA Breakthrough Device Designation for a bone graft substitute that potentially protects against microbial
Charlar en LíneaBonalive® Biomaterials Ltd. granted FDA Breakthrough Device ...
TURKU, Finland, Feb. 16, 2022 /PRNewswire/ -- The Center for Devices and Radiological Health at the Food Drug Administration has determined that Bonalive ® Orthopedics
Charlar en LíneaBonalive receives FDA breakthrough device designation for bone
2022.2.18 Bonalive Biomaterials Ltd. has been granted FDA breakthrough device designation for its Bonalive orthopedics granules, a bone graft substitute designed to
Charlar en LíneaOlympus Biotech与 BonAlive签订分销协议-美通社PR-Newswire
2013.1.21 植入性医疗器械制造商、慢性骨感染治疗适应症的新兴领导者 BonAlive Biomaterials Ltd 和专注于骨和软组织微创再生疗法的奥林巴斯 (Olympus Corporation)
Charlar en LíneaBonAlive Biomaterials Ltd erhält die CE-Kennzeichnung als ...
2013.11.26 BonAlive Biomaterials Ltd, Hersteller von implantierbaren Medizinproduktmaterialien, gab heute die Einführung eines patentierten, sofort
Charlar en Línea